Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative Lidocaine in Abdominal Surgery
NCT05541640Recruiting
- Sponsor
- Assiut University
- Start
- Oct 2022
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in postoperative pain and postoperative ileus (POI) (2 arms), sponsored by Assiut University. Primary endpoint: Visual Analogue Scale at 24 hours. Started Oct 2022; status: recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative painpostoperative ileus (POI)
Beyond the preview
Go deeper on NCT05541640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05541640.